Adler & Co.
1035 Pearl Street, Suite 400, Boulder, CO, 80302, United States
Overview
Adler & Co. represents over 50 private investment firms that are dedicated to providing liquidity and operational choices to the owners of lower middle market companies (those with revenue from $10 to $100 million). Whether you're interested in selling all, a majority or a minority stake in your company, our clients structure offers that give you choices. You may want to retire, accelerate your company's growth, or achieve some combination of the two. By working with us, you are able to create your future in ways that you might not have thought were possible. Because we work for the investors, our services are free to company owners.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Courtagen Life Sciences
Participated · Equity · Jul 2015
Courtagen is a privately held life sciences and molecular information company based in Woburn, Massachusetts that converts genomic data into actionable clinical information for diagnosis of critical pediatric neurological and metabolic disorders. The company sells proprietary genomic diagnostic and drug metabolism assays focused on mitochondrial disorders, epilepsy, and intellectual disability, including autism spectrum disorders. Its Next Generation Sequencing clinical laboratory integrates genotype, phenotype, and disease mechanism data using cloud-based computing and custom analytical methods to provide comprehensive results for clinicians, patients, and families. Courtagen recently completed a financing that adds approximately $20 million of new growth equity to its balance sheet. The company intends to use the proceeds to expand its ability to deliver services while maintaining strong financial and operating discipline. Courtagen aims to build into a world-class, global enterprise with greater capabilities, reach, and impact to help physicians treat patients.
Team
No current team members are available.